{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:45:31Z","timestamp":1793151931462,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00296-022-05146-9","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T17:02:49Z","timestamp":1654102969000},"page":"1523-1530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4471-4884","authenticated-orcid":false,"given":"Svitlana","family":"Zubchenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-5827","authenticated-orcid":false,"given":"Iryna","family":"Kril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-9481","authenticated-orcid":false,"given":"Olena","family":"Nadizhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-259X","authenticated-orcid":false,"given":"Oksana","family":"Matsyura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3127-2028","authenticated-orcid":false,"given":"Valentyna","family":"Chopyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"27","key":"5146_CR1","doi-asserted-by":"publisher","first-page":"21250617","DOI":"10.1101\/2021.01.27.21250617","volume":"01","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Preprint medRxiv 01(27):21250617. https:\/\/doi.org\/10.1101\/2021.01.27.21250617","journal-title":"Preprint medRxiv"},{"key":"5146_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.m1403","volume":"369","author":"NJ Beeching","year":"2020","unstructured":"Beeching NJ, Fletcher TE, Beadsworth MBJ (2020) Covid-19: testing times. BMJ 369:m1403. https:\/\/doi.org\/10.1136\/BMJ.m1403","journal-title":"BMJ"},{"issue":"2","key":"5146_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10067-021-06001-1","volume":"41","author":"HR Sapkota","year":"2022","unstructured":"Sapkota HR, Nune A (2022) Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol 41(2):337\u2013348. https:\/\/doi.org\/10.1007\/s10067-021-06001-1","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5146_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10067-021-05942-x","volume":"41","author":"F Karaarslan","year":"2022","unstructured":"Karaarslan F, G\u00fcneri FD, Karde\u015f S (2022) Long COVID: rheumatologic\/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol 41(1):289\u2013296. https:\/\/doi.org\/10.1007\/s10067-021-05942-x","journal-title":"Clin Rheumatol"},{"issue":"7","key":"5146_CR5","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1007\/s10067-021-05691-x","volume":"40","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Zimba O, Gasparyan AY (2021) COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol 40(7):2611\u20132619. https:\/\/doi.org\/10.1007\/s10067-021-05691-x","journal-title":"Clin Rheumatol"},{"issue":"10","key":"5146_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff D, Sun A, Ssentongo AE et al (2021) Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection. JAMA Netw Open 4(10):e2128568. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28568","journal-title":"JAMA Netw Open"},{"key":"5146_CR7","unstructured":"NICE: COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. https:\/\/www.nice.org.uk\/ guidance\/ng188"},{"key":"5146_CR8","unstructured":"Summary of ICD coding for COVID-19 21.01.2021, South African WHO-FIC Collaborating Centre https:\/\/www.who.int\/classifications\/icd\/icd10updates\/en\/"},{"key":"5146_CR9","doi-asserted-by":"publisher","unstructured":"Zubchenko S, Kril I, Lomikovska M et al. (2021) Anamnestic, clinical and laboratory data analysis of patients for drug hypersensitivity reactions Immunology and Allergy: Sci Pract 3:5\u201312. https:\/\/doi.org\/10.37321\/immunology.2021.3-01","DOI":"10.37321\/immunology.2021.3-01"},{"key":"5146_CR10","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1073\/pnas.96.5.2279","volume":"96","author":"IS Misko","year":"1999","unstructured":"Misko IS, Cross SM, Khanna R et al (1999) Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease. Proc Natl Acad Sci USA 96:2279\u20132284. https:\/\/doi.org\/10.1073\/pnas.96.5.2279","journal-title":"Proc Natl Acad Sci USA"},{"key":"5146_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jmv.24633","volume":"89","author":"M Neves","year":"2017","unstructured":"Neves M, Marinho-Dias J, Ribeiro J et al (2017) Epstein-Barr virus strains and variations: Geographic or disease-specific variants? J Med Virol 89:373\u2013387. https:\/\/doi.org\/10.1002\/jmv.24633","journal-title":"J Med Virol"},{"key":"5146_CR12","doi-asserted-by":"crossref","unstructured":"Zubchenko SO, Chopyak VV, Havrylyuk AM, Potemkina GO, Lomikovska MP(2019) Investigation of miR-BART 13 and 15 in patients with allergopathy in combination with chronic Epstein-Barr viral infection. World Med Biol15(2(68)):54\u201360 https:\/\/womab.com.ua\/en\/smb-2019-02\/7820","DOI":"10.26724\/2079-8334-2019-2-68-54-60"},{"key":"5146_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","volume":"11","author":"G Houen","year":"2021","unstructured":"Houen G, Trier NH (2021) Epstein-Barr Virus and systemic autoimmune diseases. Front Immunol 11:587380. https:\/\/doi.org\/10.3389\/fimmu.2020.587380","journal-title":"Front Immunol"},{"key":"5146_CR14","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","volume":"11","author":"T Chen","year":"2021","unstructured":"Chen T, Song J, Liu H et al (2021) Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep 11:10902. https:\/\/doi.org\/10.1038\/s41598-021-90351-y","journal-title":"Sci Rep"},{"key":"5146_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12879-021-06638-y","volume":"21","author":"Y Xie","year":"2021","unstructured":"Xie Y, Cao S, Dong H et al (2021) Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect Dis 21:955. https:\/\/doi.org\/10.1186\/s12879-021-06638-y","journal-title":"BMC Infect Dis"},{"key":"5146_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","volume":"104","author":"S Paolucci","year":"2021","unstructured":"Paolucci S, Cassaniti I, Novazzi F et al (2021) EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis 104:315\u2013319. https:\/\/doi.org\/10.1016\/j.ijid.2020.12.051","journal-title":"Int J Infect Dis"},{"issue":"3","key":"5146_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","volume":"51","author":"A Simonnet","year":"2021","unstructured":"Simonnet A, Engelmann I, Moreau AS et al (2021) High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now 51(3):296\u2013299. https:\/\/doi.org\/10.1016\/j.idnow.2021.01.005","journal-title":"Infect Dis Now"},{"key":"5146_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0830","volume":"4","author":"JK Logue","year":"2021","unstructured":"Logue JK, Franko NM, McCulloch DJ et al (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4:e210830. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0830","journal-title":"JAMA Netw Open"},{"key":"5146_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.m3026","volume":"370","author":"T Greenhalgh","year":"2020","unstructured":"Greenhalgh T, Knight M, A\u2019Court C et al (2020) Management of post-acute covid-19 in primary care. BMJ 370:m3026. https:\/\/doi.org\/10.1136\/BMJ.m3026","journal-title":"BMJ"},{"key":"5146_CR20","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2021.91","volume":"36","author":"I Al-Jahdhami","year":"2021","unstructured":"Al-Jahdhami I, Al-Naamani K, Al-Mawali A (2021) The Post-acute COVID-19 syndrome (Long COVID). Oman Med J 36:e220. https:\/\/doi.org\/10.5001\/omj.2021.91","journal-title":"Oman Med J"},{"key":"5146_CR21","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","volume":"81","author":"E Garrigues","year":"2020","unstructured":"Garrigues E, Janvier P, Kherabi Y et al (2020) Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 81:e4\u2013e6. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.029","journal-title":"J Infect"},{"key":"5146_CR22","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","volume":"397","author":"C Huang","year":"2021","unstructured":"Huang C, Huang L, Wang Y et al (2021) 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet 397:220\u2013232. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8","journal-title":"Lancet"},{"key":"5146_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113426","volume":"268","author":"F Callard","year":"2021","unstructured":"Callard F, Perego E (2021) How and why patients made Long Covid. Soc Sci Med 268:113426. https:\/\/doi.org\/10.1016\/j.socscimed.2020.113426","journal-title":"Soc Sci Med"},{"key":"5146_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-102-1-7","volume":"102","author":"SE Straus","year":"1985","unstructured":"Straus SE, Tosato G, Armstrong G et al (1985) Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102:7\u201316. https:\/\/doi.org\/10.7326\/0003-4819-102-1-7","journal-title":"Ann Intern Med"},{"key":"5146_CR25","doi-asserted-by":"publisher","unstructured":"Ariza ME (2021) Myalgic encephalomyelitis\/chronic fatigue syndrome: The human herpesviruses are back. Biomolecules 29;11(2):185. https:\/\/doi.org\/10.3390\/biom11020185.","DOI":"10.3390\/biom11020185"},{"issue":"13","key":"5146_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00192-21","volume":"95","author":"D Verma","year":"2021","unstructured":"Verma D, Church TM, Swaminathan S (2021) Epstein-Barr virus lytic replication induces ACE2 expression and enhances SARS-CoV-2 Pseudotyped virus entry in epithelial cells. J Virol 95(13):e0019221. https:\/\/doi.org\/10.1128\/JVI.00192-21","journal-title":"J Virol"},{"key":"5146_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-6-15","volume":"6","author":"SD Vernon","year":"2006","unstructured":"Vernon SD, Whistler T, Cameron B et al (2006) Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infect Dis 6:15","journal-title":"BMC Infect Dis"},{"key":"5146_CR28","doi-asserted-by":"publisher","unstructured":"Lisci M, Barton PR, Randzavola LO, et al. (2021) Mitochondrial translation is required for sustained killing by cytotoxic T cells. Science 374(6565):eabe9977. https:\/\/doi.org\/10.1126\/science.abe9977","DOI":"10.1126\/science.abe9977"},{"issue":"1","key":"5146_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/pathogens7010028","volume":"7","author":"SD Dojcinov","year":"2018","unstructured":"Dojcinov SD, Fend F, Quintanilla-Martinez L (2018) EBV-positive lymphoproliferation of B- T- and NK-cell derivation in non-immunocompromised hosts. Pathogens 7(1):28. https:\/\/doi.org\/10.3390\/pathogens7010028","journal-title":"Pathogens"},{"issue":"11","key":"5146_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108863","volume":"34","author":"EA Thompson","year":"2021","unstructured":"Thompson EA, Cascino K, Ordonez AA et al (2021) Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep 34(11):108863. https:\/\/doi.org\/10.1016\/j.celrep.2021.108863","journal-title":"Cell Rep"},{"key":"5146_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12979-021-00252-x","volume":"18","author":"AV Nunn","year":"2021","unstructured":"Nunn AV, Guy GW, Botchway SW et al (2021) SARS-CoV-2 and EBV; the cost of a second mitochondrial \u201cwhammy\u201d? Immun Ageing 18:40. https:\/\/doi.org\/10.1186\/s12979-021-00252-x","journal-title":"Immun Ageing"},{"key":"5146_CR32","doi-asserted-by":"publisher","unstructured":"Gold JE, Okyay RA, Licht WE et al. (2021) Hurley investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation pathogens 10(6):763; https:\/\/doi.org\/10.3390\/pathogens10060763.","DOI":"10.3390\/pathogens10060763"},{"issue":"8","key":"5146_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L et al (2020) Covid-19 and autoimmunity. Autoimmun Rev 19(8):102597. https:\/\/doi.org\/10.1016\/j.autrev.2020.102597","journal-title":"Autoimmun Rev"},{"key":"5146_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1328","volume":"369","author":"L Wynants","year":"2020","unstructured":"Wynants L, Van Calster B, Bonten MMJ et al (2020) Prediction models for diagnosis and prognosis of covid19: a systematic review and critical appraisal. BMJ 369:m1328. https:\/\/doi.org\/10.1136\/bmj.m1328","journal-title":"BMJ"},{"key":"5146_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s12192-020-01148-3","volume":"25","author":"MA Gammazza","year":"2020","unstructured":"Gammazza MA, L\u00e9gar\u00e9 S, Lo Bosco G et al (2020) Human molecular chaperons share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Cell Stress Chaperons 25:737\u2013741. https:\/\/doi.org\/10.1007\/s12192-020-01148-3","journal-title":"Cell Stress Chaperons"},{"key":"5146_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","volume":"78","author":"NR Jog","year":"2019","unstructured":"Jog NR, Young KA, Munroe ME et al (2019) Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk-individuals. Ann Rheum Dis 78:1235\u20131241. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215361","journal-title":"Ann Rheum Dis"},{"key":"5146_CR37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s10067-022-06092-4","volume":"41","author":"AA Drosos","year":"2022","unstructured":"Drosos AA, Pelechas E, Voulgari PV (2022) Long COVID from rheumatology perspective: a simple mimicker or promoter of autoimmunity? Clin Rheumatol 41:957\u2013958. https:\/\/doi.org\/10.1007\/s10067-022-06092-4","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-022-05146-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-022-05146-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T04:03:33Z","timestamp":1659499413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-022-05146-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5146"],"URL":"https:\/\/doi.org\/10.1007\/s00296-022-05146-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical Committee or Institutional Animal Care and Use Committee Approval: Danylo Halytsky Lviv National Medical University (22\/06\/2021 protocol \u2116 6).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}